↓ Skip to main content

Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials

Overview of attention for article published in The Journal of Headache and Pain, January 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news
2 news outlets
twitter
3 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
38 Mendeley